James DArecca is EVP, Chief Financial Officer of Haemonetics Corp.
Person profile
Roles
Haemonetics
EVP, Chief Financial Officer
Prestige Consumer Healthcare
Director
Address
Parsippany, New Jersey
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Prestige Consumer Healthcare Inc.
3 Aug 23
3
Prestige Consumer Healthcare Inc.
3 Aug 23
4
HAEMONETICS CORP
17 May 23
4
HAEMONETICS CORP
4 May 23
4
HAEMONETICS CORP
18 May 22
4
HAEMONETICS CORP
4 May 22
3
HAEMONETICS CORP
14 Apr 22
4
TherapeuticsMD, Inc.
12 Aug 21
4
TherapeuticsMD, Inc.
2 Jul 21
4/A
TherapeuticsMD, Inc.
7 Aug 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Aug 23 | PBH Prestige Consumer Healthcare | Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 0 | 2,295 | 0.00 | 2,295 |
16 May 23 | HAE Haemonetics | Common Stock | Payment of exercise | Dispose F | No | No | 89.21 | 349 | 31.13 k | 14,102 |
15 May 23 | HAE Haemonetics | Common Stock | Grant | Acquire A | No | No | 0 | 4,205 | 0.00 | 14,451 |
15 May 23 | HAE Haemonetics | NQSO Common Stock | Grant | Acquire A | No | No | 89.16 | 9,502 | 847.20 k | 9,502 |
2 May 23 | HAE Haemonetics | Common Stock | Payment of exercise | Dispose F | No | No | 81.66 | 430 | 35.11 k | 10,246 |